Abstracts tagged "interdisciplinary rheumatology team"

Abstract Number: 876 • 2019 ACR/ARP Annual Meeting
“When You Read This, You Really Feel Old!” Perspectives of Young People with Inflammatory Arthritis on Patient Reported Outcome Measures from a European Qualitative Study
Erika Mosor¹, Paul Studenic ¹, Alessia Alunno ², Ivan Padjen ³, Wendy Olsder ⁴, Sofia Ramiro ⁵, Ilaria Bini ⁶, Nele Caeyers ⁷, Laure Gossec ⁸, Marios Kouloumas ⁹, Elena Nikiphorou ¹⁰, Simon Stones ¹¹, Tanita Wilhelmer ¹² and Tanja Stamm ¹, ¹Medical University of Vienna, Vienna, Austria, ²Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy, Perugia, Italy, ³UHC Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia, ⁴Patient Research Partner, Amsterdam, Netherlands, ⁵Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands, ⁶ANMAR Young Patient Advocate, Avellino, Italy, ⁷Patient Research Partner, Brussels, Belgium, ⁸Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France, ⁹Cyprus League Against Rheumatism, Nicosia, Cyprus, ¹⁰King's College London, London, United Kingdom, ¹¹University of Leeds, Leeds, United Kingdom, ¹²Österreichische Rheumaliga, Bregenz, Austria
Background/Purpose: Although patient-reported outcome measures (PROMs) are extensively used in clinical practice and research, it is unclear whether the most commonly used instruments adequately cover…
Abstract Number: 2339 • 2019 ACR/ARP Annual Meeting
Exposure to Avian and Fungal Antigens in Patients with Rheumatoid Arthritis-AssociatedInterstitial Lung Disease: Something to Keep in Mind
Sebastian Rodriguez-Garcia¹, Raul Castellanos-Moreira ², Fernanda Hernández-González ³, Albert Perez ⁴, Joel Francesqui ⁵, Sandra Cuerpo-Cardeñosa ⁵, Virginia Ruiz-Esquide ⁶, Mariana Benegas ⁷, José Ramírez ⁸, Carmen Lucena-Pozo ³, Carlos Agustí ³, Marc Boada ⁹, Estíbaliz Ruiz ⁴, Odette Viñas ⁴, Sergio Prieto-González ¹⁰, Raimon Sanmarti ¹¹, Gerard Espinosa ¹², Mariona Pascal ¹³, Jose Gomez-Puerta ¹¹, Marcelo Sánchez ⁷ and Jacobo Sellares ³, ¹Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Spain, ²Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, ³Department of Pneumology, Hospital Clínic, Barcelona, Barcelona, Spain, ⁴Department of Immunology, Hospital Clínic, Barcelona, Barcelona, Spain, ⁵Pneumology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, ⁶Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, ⁷Department of Radiodiagnosis, Hospital Clínic, Barcelona, Barcelona, Spain, ⁸Department of Pathological Anatomy, Hospital Clínic, Barcelona, Barcelona, Spain, ⁹Department of Thoracic Surgery, Hospital Clínic, Barcelona, Barcelona, Spain, ¹⁰Department of Systemic Autoimmune Diseases Hospital Clínic, Barcelona, Barcelona, Spain, ¹¹Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain, ¹²Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, ¹³Immunology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain
Background/Purpose: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is an extra-articular manifestation with a poor prognosis. In clinical practice, to establish such a diagnosis requires…
Abstract Number: 329 • 2018 ACR/ARHP Annual Meeting
Use of Inter-Professional Collaboration to Improve Adherence to American College of Rheumatology Recommendations for Use of Disease Activity Measures
Elisheva Weinberger¹, Douglas Einstadter² and Marina Magrey¹, ¹Rheumatology, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, ²Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH
Background/Purpose: “Treat to target” is the goal of therapy in the treatment of Rheumatoid Arthritis (RA) based on the 2015 American College of Rheumatology (ACR)…
Abstract Number: 524 • 2018 ACR/ARHP Annual Meeting
Clinical Course of Interstitial Lung Disease in Rheumatoid Arthritis Patients in Clinical Practice
Cristina Vadillo Font¹, María A Nieto², Dalifer Freites Núñez³, Zulema Rosales Rosado^1,3, Leticia Leon³, Judit Font Urgelles¹, Juan A Jover Jover¹ and Lydia A Alcazar³, ¹Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²Chest diseases, Hospital Clínico San Carlos, Madrid, Spain, ³Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
Background/Purpose: Interstitial lung disease (ILD) is the extra-articular manifestation that most frequently worsens the course of Rheumatoid arthritis (RA) disease. Purpose: To describe the characteristics…
Abstract Number: 1092 • 2017 ACR/ARHP Annual Meeting
The Ottawa Biologics Safety and Screening Tool
Chrisanna Dobrowolski¹, Ines Midzic², Denise Boone², Anne McCarthy³, Doug Smith², John Thomson², Sheryl Izzi⁴ and Susan Humphrey-Murto², ¹Internal Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ²Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ³Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, ⁴Division of Endocrinology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada
Background/Purpose : A large proportion of patients with rheumatologic diseases are now being treated with biologic therapies. Estimates of the use of biologics in patients…
Abstract Number: 85 • 2016 ACR/ARHP Annual Meeting
Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach
Janet Roberts¹, Stephanie O. Keeling² and Steven J. Katz³, ¹Medicine, University of Alberta, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³Rheumatology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The University of Alberta Division of Rheumatology has launched a new multidisciplinary clinic, the On-TRACC Program (On Treating Rheumatoid Arthritis – Providing Access to…
Abstract Number: 1296 • 2015 ACR/ARHP Annual Meeting
Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team
Diane Tin¹, Lorna J. Bain¹, J Carter Thorne², Meen Jae Lee^2,3, Lois Derrick^1,4, E Jean Painter¹, Annabelle Estaban¹, Nooshin Samadi², Sue Charette¹, Sherry Hartnett¹, Carolyn Bornstein¹, Edward Ng² and Michael Aubrey², ¹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Pharmacology, McGill University, Montreal, QC, Canada, ⁴The Arthritis Society, Toronto, ON, Canada
Background/Purpose: Joint count assessment is essential for the diagnosis and ongoing evaluation of Rheumatoid Arthritis (RA) disease activity. In our team based, interprofessional approach to…
Abstract Number: 2110 • 2013 ACR/ARHP Annual Meeting
Who Will Achieve Individually Set Goals After Arthritis Team Rehabilitation?
Sofia Hagel¹, Elisabet Lindqvist² and Ann B. I. Bremander³, ¹Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ²Department of Clinical Sciences, Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ³Department of Clinical Sciences, Lund, Section of Rheumatology, Lund, Lund University, Lund, Sweden
Background/Purpose: To study goal achievement among patients with chronic inflammatory arthritis after arthritis rehabilitation performed in multidisciplinary team rehabilitation programs. Methods: 146 consecutive patients with…
Abstract Number: 983 • 2013 ACR/ARHP Annual Meeting
Teaching Musculoskeletal Care Through An Inter-Disciplinary and Inter-Professional Clinical Training Program Successfully Provides Trainees With Knowledge and Skills Required To Deliver Excellent Musculoskeletal Care
Grant W. Cannon¹, Andrea Barker², J Peter Beck³, Jeffery Berdan³, Marissa Grotzke⁴, Timothy A. Huhtala⁵, Patrice Kennedy⁶, Phillip Lawrence³, JoAnn Rolando³ and Michael J. Battistone¹, ¹Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ²General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ³Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁴Division of Endocrinology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁵Division of General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁶500 Foothill Boulevard, Salt Lake City VA, Salt Lake City, UT
Background/Purpose: While musculoskeletal (MSK) complaints are some of the most common reasons for primary care and specialty visits, little time is dedicated to this…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].